CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML.

Molica, Matteo; Perrone, Salvatore; Mazzone, Carla; Cesini, Laura; Canichella, Martina; de Fabritiis, Paolo

Molica, Matteo; Perrone, Salvatore; Mazzone, Carla; Cesini, Laura; Canichella, Martina; de Fabritiis, Paolo.

Afiliação

Molica M; Hematology Unit, S. Eugenio Hospital, ASL Roma 2, 00144 Rome, Italy.
Perrone S; Hematology, Polo Universitario Pontino, S.M. Goretti Hospital, 04100 Latina, Italy.
Mazzone C; Hematology Unit, S. Eugenio Hospital, ASL Roma 2, 00144 Rome, Italy.
Cesini L; Hematology Unit, S. Eugenio Hospital, ASL Roma 2, 00144 Rome, Italy.
Canichella M; Hematology Unit, S. Eugenio Hospital, ASL Roma 2, 00144 Rome, Italy.
de Fabritiis P; Hematology Unit, S. Eugenio Hospital, ASL Roma 2, 00144 Rome, Italy.

Cancers (Basel) ; 14(12)2022 Jun 08.

Article em En | MEDLINE | ID: mdl-35740508

Palavras-chave

CPX-351; acute myeloid leukemia; acute myeloid leukemia with myelodysplasia-related changes; therapy-related acute myeloid leukemia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google